Aurobindo Pharma Said Its Fiscal Third Quarter Profit Rose 2.8 Percent

Aurobindo Pharma said its fiscal third-quarter profit rose 2.8 percent to Rs 595 crore, helped by higher sales of generic drugs in US and Europe markets.

The company posted a net profit of Rs 579 crore in the same period previous year. Total revenue rose 11.2 percent to Rs 4369.2 crore.

The company took a one-time charge of Rs 66.4 crore for the quarter due to US deferred tax assets and liabilities based on the new tax law which has resulted in reduction in federal corporate tax from 35 percent to 21 percent.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory